Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SOPHiA GENETICS (SOPH) Return on Equity (2021 - 2025)

SOPHiA GENETICS's Return on Equity history spans 5 years, with the latest figure at 0.01% for Q4 2025.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Equity hit 0.01% in Q4 2025 for SOPHiA GENETICS, down from 0.07% in the prior quarter.
  • Over the last five years, Return on Equity for SOPH hit a ceiling of 7.06% in Q1 2021 and a floor of 0.09% in Q2 2024.
  • Historically, Return on Equity has averaged 0.6% across 5 years, with a median of 0.02% in 2023.
  • The widest YoY moves for Return on Equity: up 6bps in 2022, down -704bps in 2022.
  • Tracing SOPH's Return on Equity over 5 years: stood at 0.01% in 2021, then decreased by -6bps to 0.01% in 2022, then grew by 7bps to 0.01% in 2023, then decreased by -6bps to 0.01% in 2024, then grew by 0bps to 0.01% in 2025.
  • Business Quant data shows Return on Equity for SOPH at 0.01% in Q4 2025, 0.07% in Q3 2025, and 0.06% in Q2 2025.